Transcatheter Interventions Online 2024 - On Demand

Prof Nicolas Maria Van Mieghem is an Interventional cardiologist at Thoraxcenter, Erasmus MC, Rotterdam, NL decided to pursue a career that would help others. “I enjoy the feeling of being able to help someone or do something important for them". His father was a general cardiologist and one of his biggest influences early in his career.

Prof Van Mieghem initially intended to train as a cardiac surgeon but decided to specialise in interventional cardiology instead, following advice from a mentor. This decision was cemented when he read the first-in-human case report of transcatheter aortic valve implantation (TAVI) in Circulation by Alain Cribier in 2002. Prof Van Mieghem believes that great cardiologist genuinely cares for their patients. He names Gary Roubin, Dr Manu Malbrain and Professor Patrick Serruys among his mentors. 

His current research focuses on cerebral embolic protection during TAVI and the search for improved…

Prof Ole De Backer is an internationally renowned interventional cardiologist working at Rigshospitalet, Copenhagen University Hospital, Denmark and is an expert in structural heart interventions – among others transcatheter heart valve interventions, percutaneous left atrial appendage closure and thoracic endovascular aortic repair. Special areas of interest are the development and adoption of a fully percutaneous, minimal invasive approach for different structural heart interventions and the use of advanced cardiac imaging tools for planning and guidance of these interventions. He is actively involved and leading several research projects in the field of transcatheter heart valves and percutaneous left atrial appendage closure. 

Dr Kendra Grubb is the surgical director of the Emory Structural Heart and Valve Center. She is also an associate professor of surgery at Emory University School of Medicine.

Kendra is a champion for women's heart disease and is dedicated to improving the lives of all patients through innovation, collaboration and a patient-centred approach to the treatment of cardiovascular disease.

Her clinical interests include valve repair or replacement, coronary artery bypass graft surgery (CABG), transcatheter aortic valve replacement (TAVR) and hybrid coronary revascularization.

Dr Grubb research interests are innovative cardiac surgery technologies. She has led and participated in multiple clinical trials of innovative cardiac surgery technologies, including studies of transcatheter aortic valve replacement (TAVR), MitraClip percutaneous therapy and the GORE® conformable TAG® thoracic endoprosthesis for the primary treatment of…

Dr Mohamed Azeem Latib is a world-leading expert in Interventional Cardiology. Dr Latib is the Section Head and Director of Interventional Cardiology as well as the Director of Structural Heart Interventions at the Montefiore-Einstein Center for Heart and Vascular Care. 

He is an editorial board member of Interventional Cardiology: Reviews, Research, Resources (ICR3).

His focus is on complex coronary interventions as well as transcatheter aortic, mitral and tricuspid interventions. His main clinical interests include Complex Coronary Interventions, Structural Heart Disease and New Device Innovation. He has extensive clinical experience in TAVR and MitraClip, as well as expertise in novel and new devices to treat mitral and tricuspid valve disease minimally invasively without open-heart surgery.

Dr Latib is currently involved in the development of the NeoChord NeXuS Transcatheter Mitral Chordal…

Didier Tchétché, (Clinique Pasteur, Toulouse, France) Graduated from the University of Paris V where Dr Tchétché obtained his post-graduate diploma of cardiovascular pathology in 2004. From 2004 to 2005, he completed a 12-month fellowship period in the Hemodynamic and Interventional Cardiology department of Clinique Pasteur in Toulouse and from 2005 to 2007 he was Head Assistant at the intensive care unit of Bichât Hospital in Paris.

In 2008, he joined the interventional cardiovascular group in Clinique Pasteur, Toulouse, and he is currently Head of the Structural programme with an experience of more than 5000 TAVI procedures. His main areas of interest are coronary interventions and valvular heart disease. He has been actively involved in many clinical trials involving new technologies and devices in the field of interventional cardiology.